These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33447762)

  • 1. Trends in ambulatory blood pressure monitoring use for confirmation or monitoring of hypertension and resistant hypertension among the commercially insured in the U.S., 2008-2017.
    Desai R; Park H; Dietrich EA; Smith SM
    Int J Cardiol Hypertens; 2020 Sep; 6():100033. PubMed ID: 33447762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States.
    Desai R; Dietrich EA; Park H; Smith SM
    Am J Hypertens; 2020 Nov; 33(11):999-1002. PubMed ID: 32930343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace.
    Dietrich E; Desai R; Garg M; Park H; Smith SM
    J Clin Hypertens (Greenwich); 2020 Jan; 22(1):6-15. PubMed ID: 31873973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
    Staessen JA; Beilin L; Parati G; Waeber B; White W
    Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.
    Shimbo D; Kent ST; Diaz KM; Huang L; Viera AJ; Kilgore M; Oparil S; Muntner P
    J Am Soc Hypertens; 2014 Dec; 8(12):891-7. PubMed ID: 25492832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis.
    Vareta G; Georgianos PI; Vaios V; Sgouropoulou V; Georgianou EI; Leivaditis K; Mavromatidis K; Dounousi E; Papagianni A; Balaskas EV; Zebekakis PE; Liakopoulos V
    Am J Hypertens; 2022 Nov; 35(11):918-922. PubMed ID: 35882382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care.
    Hayes P; Casey M; Glynn LG; Molloy GJ; Durand H; O'Brien E; Dolan E; Newell J; Murphy AW
    Br J Gen Pract; 2018 Jun; 68(671):e394-e400. PubMed ID: 29739776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates, amounts, and determinants of ambulatory blood pressure monitoring claim reimbursements among Medicare beneficiaries.
    Kent ST; Shimbo D; Huang L; Diaz KM; Viera AJ; Kilgore M; Oparil S; Muntner P
    J Am Soc Hypertens; 2014 Dec; 8(12):898-908. PubMed ID: 25492833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.
    Muxfeldt ES; Fiszman R; de Souza F; Viegas B; Oliveira FC; Salles GF
    Hypertension; 2012 Feb; 59(2):384-9. PubMed ID: 22215711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Correlates of Ambulatory Blood Pressure Phenotypes at a Tertiary Care Hospital in Turkey.
    Erdogmus S; Kutlay S; Celebi ZK; Aydın T; Ors Sendogan D; Kumru G; Keven K; Nergizoglu G; Erturk S; Sengul S
    Kidney Blood Press Res; 2018; 43(3):690-700. PubMed ID: 29763911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of Office versus Ambulatory Blood Pressure in Kidney Transplant Recipients.
    Korogiannou M; Sarafidis P; Theodorakopoulou MP; Alexandrou ME; Xagas E; Boletis IN; Marinaki S
    Am J Nephrol; 2021; 52(7):548-558. PubMed ID: 34311458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and characteristics of apparent treatment-resistant hypertension in older people in China: a cross-sectional study.
    Wu C; Wang Y; Zhang W; Li X; Wang L; Hui R
    Clin Exp Hypertens; 2019; 41(8):753-758. PubMed ID: 30512984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension.
    Georges CMG; Ritscher S; Pappaccogli M; Petit G; Lopez-Sublet M; Bapolisi A; Di Monaco S; Wallemacq P; Rabbia F; Toennes SW; de Timary P; Persu A
    Blood Press; 2022 Dec; 31(1):169-177. PubMed ID: 35899361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
    Vemulapalli S; Deng L; Patel MR; Kilgore ML; Jones WS; Curtis LH; Irvin MR; Svetkey LP; Shimbo D; Calhoun DA; Muntner P
    Am Heart J; 2017 Apr; 186():29-39. PubMed ID: 28454830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What happened after birth to pregnant women undergoing ambulatory blood pressure monitoring (ABPM) for the diagnosis of hypertension?
    Lima JMO; Lobo RU; Rodrigues DHDS; Viana AB; Silva RP
    J Hum Hypertens; 2020 Dec; 34(12):814-817. PubMed ID: 33005015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.
    An J; Sim JJ; Calhoun DA; Liu R; Wei R; Zhou H; Luong T; Reynolds K
    J Hypertens; 2020 Aug; 38(8):1603-1611. PubMed ID: 32251197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnitude of Hypotension Based on Office and Ambulatory Blood Pressure Monitoring: Results From a Cohort of 5066 Treated Hypertensive Patients Aged 80 Years and Older.
    Divisón-Garrote JA; Ruilope LM; de la Sierra A; de la Cruz JJ; Vinyoles E; Gorostidi M; Escobar-Cervantes C; Velilla-Zancada SM; Segura J; Banegas JR
    J Am Med Dir Assoc; 2017 May; 18(5):452.e1-452.e6. PubMed ID: 28246017
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.